A New Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Associated With Immune Infiltration: Implications for COVID-19

Abstract

SARS-CoV-2, the current severe acute respiratory syndrome coronavirus, has spread

around the world and is posing a major danger to human life, particularly for cancer

patients. Therefore, we aimed to ascertain the clinical functions of ACE2, the SARS-

CoV-2 cell entry receptor, in clear cell renal cell carcinoma (ccRCC). The prognostic and

clinicopathological features of ACE2 were ascertained using immunohistochemistry,

western blot findings, and the TCGA, GEO, and TIP datasets.